HOME

Team

Contact

Prion research Göttingen

 

Publikationen

2009

Schmitz, M., Klöppner, S., Klopfleisch, S., Möbius, W., Schwartz, P., Zerr, I. Althaus, H. H. Mutual effects of caveolin and nerve growth factor signaling in pig oligodendrocytes. J Neurosci Res, 2009 epub ahead of print

Zerr, I., Kallenberg, K., Summers, D. M., Romero, C., Taratuto, A., Heinemann, U., Breithaupt, M., Varges, D., Meissner, B., Ladogana, A., Schuur, M., Haik, S., Collins, S. J., Jansen, G. H., Stokin, G. B., Pimentel, J., Hewer, E., Collie, D., Smith, P., Roberts, H., Brandel, J. P., van Dujin, C., Pocchiari, M., Begue, C., Cras, P., Will, R. G., Sanchez-Juan, P. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain, 2009 epub ahead of print

Parchi, P., Strammiello, R., Notari, S., Giese, A., Langeveld, J. P., Ladogana, A., Zerr, I., Roncaroli, F., Cras, P., Ghetti, B., Pocchiari, M., Kretzschmar, H., Capellari, S. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrP(Sc) types: an updated classification. Acta Neuropahol, 2009 epub ahead of print

Meissner, B., Kallenberg, K., Sanchez-Juan, P., Collie, D., Summers, DM., Almonti, S., Collins, SJ., Smith, P., Cras, P., Janses, GH., Brandel JP, Coulthard, MB., Roberts, H., van Everbroeck, B., Galanaud, D., Mellina, V., Will, RG., Zerr, I. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology, 2009;72(23):1994-2001

Kovacs, G., Sanchez-Juan, P., Ströbel, T., Schuur, M., Poleggi, A., Nocentini, S., Giannattasio, C., Belay, G., Bishop, M., Capellari, S., Parchi, P., Gelpi, E., Gal, A., Bakos, A., Molnar, M., Heinemann, U., Zerr, I., Knight, R., Mitrova, E, van Duijn, C., Budka, H. Cathepsin D (C224T) polymorphism in sporadic and genetic Creutzfeldt-Jakob disease. Alzheimer Dis Assoc Disord 2009 epub ahead of print

Kittner, C., Heinemann, U., Zerr, I. Risk factors for sporadic Creutzfeldt-Jakob disease. Dtsch Med Wochenschr 2009;134(27):1429-35.

Albrecht, P., Schmitz, M., Otto, M., Hemmer, B., Zerr, I., Hartung, H-P., Methner, A.Free caspase activity in CSF of patients with dementia J Neurology, 2009 epub ahead of print

Meyne, F., Gloeckner, S., Ciesielczyk, B., Hienemann, U., Krasnianski, A., Meissner, B., Zerr, I. Total prion protein levels in the cerebrospinal fluid in patients with various neurodegenerative disorders. J Alz Dis, 2009 epub ahead of print

Ladogana, A., Sanchez-Juan, P., Mitrová, E., Green, A., Cuadrado-Corrales, N., Sánchez-Valle, R., Koscova, S., Aguzzi, A., Sklaviadis, T., Kulczycki, J., Gawinecka, J., Saiz, A., Calero, M., van Duijn, CM., Pocchiari, M., Knight, R., Zerr, I. J Neurol, 2009;256:1620-8 Epub

Albrecht, P., Schmitz, M., Otto, M., Hemmer, B., Zerr, I., Hartung, H. P., Methner, A. Free caspase activity in CSF of patients with dementia. J Neurol, 2009;256:1561-2 Epub

Dabaghian, R., Zerr, I., Heinemann, U., Zanusso, G. Detection of proteinase K resistant proteins in the urine of patients with Creutzfeldt-Jakob and other neurodegenerative diseases. Prion, 2009;2:170-8

Meissner, B., Kallenberg, K., Ramljak, S., Krasnianski, A., Heinemann, U., Krebs, B., Budka, H., Barcic, A., Kretzschmar, H.A., Knauth, M., Schulz-Schaeffer, W.J., Zerr I. MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease. J Neurology, 2009;256:355-63 Epub

Edler, J., Mollenhauer, B., Heinemann, U., Varges, D., Werner, C., Zerr, I., Schulz-Schaeffer, WJ. Movement disturbances in the differential diagnosis of Creutzfeldt-Jakob disease. Mov Dis, 2009 15;  24 (3):350-356

2008

Miele, G., Seeger, H., Marino, D., Eberhard, R, Haikenwalder, M., Stoeck, K., Basagni, M., Knight, R., Green, A., Chiani,  F., Wüthrich, RP., Hock, C., Zerr, I., Aguzzi, A. Urinary alpha1-antichymotrypsin: a biomarker of prion infection. PLoS ONE. 2008; 3(12):e 3870 Epub 2008 Dec 5.

Weise J, Doeppner TR, Müller T, Wrede A, Schulz-Schaeffer W, Zerr I, Witte OW, Bähr M. Overexpression of cellular prion protein alters postischemic Erk1/2 phosphorylation but not Akt phosphorylation and protects against focal cerebral ischemia. Restor Neurol Neurosci. 2008;26(1):57-64

Roeber, S., Grasbon-Frodl, EM, Windl, O., Krebs, B., Xiang, W., Vollmert, C., Illig, T., Schröter, A., Arzberger, T., Weber, P., Zerr, I., Kretzschmar, HA. Evidence for a pathogenic role of different mutations at codon 188 of PRNP. PLoS ONE 2008 ;3(5):e2147

Krasnianski, A., Kallenberg, K., Collie, D.A., Meissner, B., Schulz-Schaeffer, W.J., Heinemann, U., Summers, D.M., Kretzschmar, H.A., Will, R.G., Zerr, I. MRI in the classical MM1 and the atypical MV2 subtype of sporadic CJD: an inter-observer agreement study. 2008, Eur J Neurology, 2008, 15: 762-771

Ramljak, S., Asif, AR, Armstrong VW, Wrede A, Groschup, M, Buschmann, A,  Schulz-Schaeffer, W, Bodemer, W. Zerr, I. Physiological role of the cellular prion protein (PrPc): protein profiling study in two cell culture systems. Journal of Proteome Research, 2008, 7(7): 2681-95

Krasnianski, A., Bartl, M., Sanchez Juan, PJ., Heinemann, U., Meissner, B., Varges, D., Schulze-Sturm, U., Schulz-Schaeffer, WJ, Kretzschmar, HA, I. Zerr, I. Fatal familial insomnia: clinical features and early identification. Annals of Neurology, 2008; 63(5):658-61

Gloeckner, S.F., Meyne, F., Wagner, F., Heinemann, U., Krasnianski, A., Meissner, B.,  Zerr, I. Transthyretin, tau and ß-Amyloid in clinical differential diagnosis of dementia. J Alz Dis, 2008, 14: 17-25

Gmitterová , K., Heinemann, U., Bodemer, M., Krasnianski , A.,  Meissner, B., Kretzschmar, HA.,  Zerr , I.14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes Neurobiol Aging, 2008, Mar 5 (Epub ahead of print)

Krasnianski, A., von Ahsen, N., Heinemann, U., Meissner, B., Kretzschmar, HA., Armstrong, V., Zerr, I. ApoE distribution and family history in genetic prion diseases  in Germany. Journal Mol Neurosci, 2008; 34(1):45-50

Rodríguez-Martínez A, Alfonso-Sánchez M, Peña, J, Zarranz J., Calero, M., Capellari, S., Sánchez-Valle, R., Zerr, I., de Pancorbo, M. Molecular evidence of founder effects of Fatal Familial Insomnia through SNP haplotypes around the D178N mutation. Neurogenetics, 2008, 9:109-118

Heinemann, U., Krasnianski, A., Meissner, B., Kallenberg, K., Schulz-Schaeffer, W. J., Zerr, I. Brain biopsy in patients with suspected Creutzfeldt-Jakob disease. J Neurosurg, 2008; 109(4): 735-41

Dabaghian, R., Zerr, I., Zanusso, G., Heinemann, U., Clewley, J. Detection of Proteinase K resistant proteins in the urine of patients with Creutzfeldt-Jakob and other neurodegenerative diseases. Prion,  2008 2(4):170-8

Heinemann, U., Krasnianski, A., Meissner, B., Grasbon-Frodl, E., Kretzschmar, H.A., Zerr I. Novel PRNP mutation in a patient with a slow progressive dementia syndrome. Med Sci Monitor, 2008; 14(5): CS41-43

Meissner, B., Kallenberg, K., Sanchez-Juan, P., Krasnianski, A., Heinemann, U., Varges, D., Knauth, M., Zerr ,I. Isolated cortical signal increase on the MRI as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease. Am J Neurorad 2008, 29:1519-24

Friedrich, M., Körte, R., Portero, C., Arzberger, T., Kretszchmar, HA, Zerr, I., Nacimiento, W. Fatal Familial Insomnia-a rare differential diagnosis in dementia. Fortsch Neurol Psychiatr 2008, 76 (1):36-40

2007
Zuber, Ch., Miteregger, G., Pace, C., Zerr, I., Kretzschmar, HA, Weiss, S. Anti-LRP/LR-Antibody W3 hampers peripheral PrPSc propagation in Scrapie infected mice. Prion, 2007 Jul; 1(3):207-12

Krebs, B., Bader, B., Klehmet, J., Grasbon-Frodl, E., Oertel, WH., Zerr, I., Stricker, S., Zschenderlein, R., Kretszchmar HA. A novel subtype of Creutzfeldt-Jakob disease characterized by a small 6 kDa PrP fragment. Acta Neuropathol (Berl) 2007; 114(2):195-9

Krasnianski, A., von Ahsen, N., Heinemann, U., Meissner, B., Schulz-Schaeffer, W.J., Kretzschmar, H.A., Armstrong, V.W., Zerr, I. Increased frequency of positive family history of dementia in sporadic CJD. 2007, Neurobiol Aging, 30 (2009), 615-621

Beekes, M., Zerr, I., Groschup M., Prion Research: Past, Present and Future. Veterinary Microbilogy Vet Microbiol 2007; 123: 285-286

Heinemann, U., Krasnianski, A., Meissner, B., Kretzschamar, H. A., Zerr, I. Molecular subtype-specific clinical diagnosis of prion disease. Vet Microbiol 2007; 123 (4): 328-335

Tschampa, H. J., Kallenberg, K., Meissner, B.,Kretzschmar, H. A., Knauth, M., Urbach, H. Zerr, I. Pattern of cortical changes in sporadic Creutzfeldt-Jakob diseasee. Am  J Neurorad; 2007; 28(6): 1114-8

Heinemann, U., Krasnianski, A., Meissner, B., Varges, D., Bartl, M., Stoeck, K., Kallenberg, K., Schulz-Schaeffer, W.J., Steinhoff, B.J., Kretzschmar, H.A., Zerr, I. Creutzfeldt-Jakob disease in Germany: a prospective 12-years surveillance. Brain 2007; 1330 (5): 1350-9

Green, A., Sanchez-Juan, P., Ladogana, A., Cuadrado-Corrales, N., Sánchez-Valle, R., Mitrová, E., Stoeck, K., Sklaviadis, T., Kulczycki, J., Heinemann, U., Hess, K., Slivarichová, D., Saiz, A., Calero, M., Ingrosso, L., Knight, R., van Duijn, C., Zerr, I. CSF analysis in patients with sporadic CJD and other transmissible spongifom encephalopathies. Eur J Neurology 2007, 14: 121-124

Dietz, K., Raddatz, G., Wallis, J., Müller, N., Zerr, I., Duerr, H-P., Lefévre, Seifried, E., Löwer, J. Blood transfusion and spread of variant Creutzfeldt-Jakob disease. Emerg Infect Dis; 2007 Jan; 13(1):89-96

Sanchez-Juan, P., Sánchez-Valle, R., Green, Ladogana, A., Cuadrado-Corrales,  N., Mitrová, E., Stoeck, K., Sklaviadis, T.,  Kulczycki, J., Hess, K., Krasnianski, A., Equestre, M., Slivarichová , D., Saiz, A., Calero, M., Pocchiari, M., Knight, R., van Duijn, CM., Zerr, I. Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurology, 2007, 254(7):901-6

Tschampa, H. J., Zerr, I., Urbach, H. Radiological assessment of Creutzfeldt-Jakob disease. European Radiology 2007,17 (5):1200-11

2006
de Pedro-Cuesta, J., Glatzel, M., Almazan, J., Stoeck, K., Mellina, V., Puopolo, M., Pocchiari, M., Zerr, I., Kretzschmar, HA, Brandel, JP., Delasnerie-Laupretre, N., Alperovitch,  A., van Duijn, C., Sanchez-Juan, P., Collins, S., Lewis, V., Jansen, GH., Coulthart, MB., Gelpi, E., Budka H., Mitrova, E. Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002. BMC Public Health, 2006, 6: 278

Krasnianski, A., Schulz-Schaeffer, W. J., Kallenberg, K., Meißner, B., Collie, D. A., Roeber, S., Bartl, M.  Heinemann, U., Varges, D., Kretzschmar, H. A., Zerr, I. Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD. Brain 2006;129:2288-96.

Sanchez-Juan, P., Green, A., Ladogana, A., Cuadrado-Corrales, N., Sánchez-Valle, R., Mitrova, E., Stoeck, K., Sklaviadis, T., Kulczycki, J., Hess, K., Bodemer, M., Slivarichová, D., Saiz, A., Calero, M., Ingrosso, L., Knight, R., Janssens, A. C. J. W. van Duijn, C. Zerr, I. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006;67 (4):637-43

Kallenberg, K., Schulz-Schaeffer, W. J., Jastrow, U., Poser, S. Meissner, B., Tschampa, H. J., Zerr, I., Knauth, M. MR imaging of Creutzfeldt-Jakob disease (CJD): Comparative analysis of MR sequences. Am J Neuroradiol 2006;27(7):1459-62.

Vollmert, C., Windl, O., Xiang, W., Rosenberger, A., Zerr, I., Wichmann, H. E.,  Bickeböller, H., Illig, T., Kretzschmar, H. A. and the KORA group. Significant association of a M129V independent polymorphism in the 5’ UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case control study. J Med Genet 2006;43(10):e53.

Geldermann, H., Bartenschlager, H., Preuss, S., Melchinger-Wild, E., Herzog, K., Zerr, I. Polymorphic microsatellite sites in the PRNP region point to excess of homozygotes in Creutzfeldt-Jakob disease patients. Gene 2006;382:66-70

Collins, S. J., Sanchez-Juan, P., Masters, C. M. L., Klug, G. M., van Duijn, C., Poleggi, A., Pocchiari, M., Almonti, S., Cuadrado-Corrales, N., de Pedro-Cuesta, J., Budka, H., Gelpi, E., Glatzel, M., Tolnay, M., Hewer, E., Zerr, I., Heinemann, U., Kretzschmar, H. A., Jansen, G. H., Olsen, E., Mitrova, E., Alpérovitch, A., Brandel, J-P., Mackenzie, J., Murray, K., Will, R. G. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic CJD. Brain 2006; 129:2278-87

Boesenberg, C., Schulz-Schaeffer, W. J., Bodemer, M, Ciesielczyck, B., Meissner, B.,Krasnianski, A., Bartl, M., Heinemann, U., Varges, D., Eigenbrod, S., Kretzschmar, H. A., Green, A., Zerr, I. Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD? BMC Neurology 2006; 6:35

Weise, J., Sandau, R., Schwarting, S., Crome, O., Wrede, A., Schulz-Schaeffer, W., Zerr, I. Bähr, M. Deletion of Cellular Prion Protein Results in Reduced Akt Activation, Enhanced Postischemic Caspase-3 Activation, and Exacerbation of Ischemic Brain Injury. Stroke 2006;37(5):1296-300.

Krasnianski, A., Meissner, B., Schulz-Schaeffer, W. J., Kallenberg, K., Bartl, M., Heinemann, U., Varges, D., Kretzschmar, H. A., Zerr, I. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2006;63(6):876-80.

Stoeck, K., Bodemer, M., Zerr, I. Pro- and antiinflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease. Journal of Neuroimmunology 2006; (1-2): 172.

2005
Meissner, B., Westner, I. M., Kallenberg, K., Krasnianski, A., Bartl, M., Varges, D., Bösenberg, C., Kretzschmar, H. A., Knauth, M., Schulz-Schaeffer, W. J., Zerr, I. Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type. Neurology 2005; 65: 1544-50.

Xiang, W., Windl, O., Westner, I. M., Neumann, M., Zerr, I., Lederer, R. M., Kretzschmar, H. A. Cerebral gene expression profiles in sporadic Creutzfeldt-Jakob disease. Ann Neurol 2005; 58: 242-57.

Boesenberg, C., Schulz-Schaeffer, W., Meissner, B., Kallenberg, K., Bartl, M., Heinemann, U., Krasnianski, A., Stoeck, K., Varges, D., Windl, O., Kretzschmar, H. A., Zerr, I. Clinical course in young sporadic CJD patients. Ann Neurol 2005; 58: 533-543.

Stoeck, K., Bodemer, M., Ciesielczyk, B., Meissner, B., Bartl, M., Heinemann, U., Zerr, I. Interleukin 4 and Interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Arch Neurol 2005; 62: 1591-4.

Kovacs, G. G., Puopolo, M., Ladogana, A., Pocchiari, M., Budka, H., van Duijn, C., Collins, S. J., Boyd, A., Giulivi, A., Coulthart, M., Delasnerie-Laupretre, N., Brandel, J. P., Zerr, I., Kretzschmar, H. A., de Pedro-Cuesta, J., Calero-Lara, M., Glatzel, M., Aguzzi, A., Bishop, M., Knight, R., Belay, G., Will, R., Mitrova, E. Genetic prion disease: the EUROCJD experience. Hum Genet 2005; 118 (2): 166-74.

Tschampa, H., Kallenberg, K., Urbach, H., Meissner, B., Nicolay, C., Kretzschmar, H. A., Knauth, M.,  Zerr, I. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain 2005; 128: 2026-33.

Jacobi, C., Arlt, S., Reiber, H., Westner, I., Kretzschmar, H. A., Poser, S., Zerr, I. Immunoglobulins and virus-specific antibodies in patients with Creutzfeldt-Jakob disease. Acta Neurol Scand 2005; 111: 185-190.

Cepek, L., Steinacker, P., Mollenhauer, B., Wiese, B., Ciesielczyk, B. Bibl, M., Wiltfang, J., Zerr, I., Schulz-Schaeffer, W., Kretzschmar, H. A., Poser, S., Otto, M. Follow-up investigations of tau protein and S-100b levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 2005; 19: 376-382.

Ladogana, A., Puopolo, M., Croes, E. A., Budka, H., Jarius, C., Collins, S., Klug, G. M., Sutcliffe, T., Giulivi, A., Alperovitch, A., Delasnerie-Laupretre, N., Brandel, J.-P., Poser, S., Kretzschmar, H., Rietveld, I., Mitrova, E., de Pedro-Cuesta, J., Martinez-Martin, P., Glatzel, M., Aguzzi, A., Knight, R., Ward, H., Pocchiari, M., van Duijn, C. M., Will, R. G., Zerr, I. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 2005; 64: 1586-1591.

Bleich, S., Otto, M., Zerr, I., Kropp, S., Kretzschmar, H. A., Wiltfang, J. Creutzfeldt-Jakob disease and homocysteine levels in plasma and cerebrospinal fluid. Gerontology 2005; 51: 142-144.

Krebs, B., Lederer, R.-M., Windl, O., Grasbon-Frodl, E.-M., Zerr, I., Kretzschmar, H. A. Creutzfeldt-Jakob disease associated with an R148H mutation of the prion protein gene. Neurogenetics 2005; 6: 97-100.

Roeber, S., Krebs, B., Neumann, M., Windl, O., Zerr, I., Grasbon-Frodl, E. M., Kretzschmar, H. A. Creutzfeldt-Jakob disease in a patient with an R208H mutation of the prion protein gene (PRNP) and a 17-kDa prion protein fragment. Acta Neuropathol (Berl.) 2005; 109(4): 443-8.

2004
Grasbon-Frodl, E., Schmalzbauer, R., Weber, P., Krebs, B., Windl, O., Zerr, I., Kretzschmar, H. A. A novel three extra-repeat insertion in the prion protein gene (PRNP) in a patient with Creutzfeldt-Jakob disease. Neurogenetics 2004; 4:249-50.

Zerr, I., Bodemer, M., Poser, S., Kaboth, U., Oellerich, M., Armstrong, V. W. Plasminogen activities and concentrations in patients with sporadic Creutzfeldt-Jakob disease. Neuroscience Letters  2004; 371: 163-166.

Weise, J., Sandau, R., Crone, O., Baehr, M., Zerr, I. Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neuroscience Letters 2004; 372: 146-50.

Pocchiari, M., Puopolo, M., Croes, EA., Budka, H., Gelpi, E., Collins, S., Lewis, V., Sutcliffe, T., Guilivi, A., Delasnerie-Laupretre, N., Brandel, JP., Alperovitch, A., Zerr, I., Poser, S., Kretzschmar, HA., Ladogana, A., Rietvald, I., Mitrova, E., Martinez-Martin, P. De Pedro-Cuesta, J., Glatzel, M., Aguzzi, A., Cooper, S., Mackenzie, J., Van Duijn, CM., Will, RG. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 2004; 127: 2348-59.

Meissner, B., Köhler, K., Körtner, K., Bartl, M., Jastrow, U., Mollenhauer, B., Schröter, A., Finkenstaedt, M., Windl, O., Poser S., Kretzschmar, H.A., Zerr, I. Sporadic Creutzfeldt-Jakob disease: Magnetic resonance imaging and clinical findings. Neurology 2004; 63: 450-56.

Steinhoff, J. B., Zerr, I., Glatting, M., Schulz-Schaeffer, W., Kretzschmar, H. A., Poser, S. The diagnostic value of periodic sharp wave complexes in the diagnosis of sporadic Creutzfeldt-Jakob disease - a study in 150 autoptically verified versus 56 autoptically excluded cases. Ann Neurol 2004; 56: 1-6

2003
Kretzschmar, H. A., Sethi, S., Földvári, Z., Windl, O., Querner, V., Zerr I., Poser, S. Iatrogenic Creutzfeldt-Jakob disease with florid plaques. Brain Pathology 2003; 13: 245-249.

Wiltfang, J., Esselmann, H., Smirnov, A., Bibl, M., Cepek, L., Steinacker, P., Mollenhauer, B., Buerger, K., Hampel, H., Paul, S., Neumann, M., Maler, M., Zerr, I., Kornhuber, J., Kretzschmar, H. A., Poser, S., Otto, M. Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Ann Neurol 2003; 54(2): 263-267

Mollenhauer, B., Serafin, S., Zerr, I., Steinhoff, B. J., Otto, M., Scherer, M., Schulz-Schaeffer, W. J., Poser, S. Diagnostic problems during late course in Creutzfeldt-Jakob disease. J Neurol 2003; 250: 629-630.

2002
Ward H. J. T., Everington D., Croes E. A., Alpérovitch A., Delasnerie-Lauprêtre N., Zerr I., Poser, S., van Duijn, C. M. (for the European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD)). Sporadic Creutzfeldt-Jakob disease and surgery - a case control study using community controls. Neurology 2002; 59: 543-548.

Tschampa, H. J., Herms, J. W., Schulz-Schaeffer, W. J., Maruschak, B., Windl, O., Jastrow, U., Zerr, I., Steinhoff, B. J., Poser, S., Kretzschmar, H. A. Clinical findings in sporadic Creutzfeldt-Jakob disease correlate with thalamic pathology. Brain 2002;125:2558-2566

Henkel, K., Zerr, I., Hertel, A., Gratz, K.-F., Schröter, A., Tschampa, H. J., Bihl, H., Büll, U., Grünwald, F., Drzezga, A., Spitz, J., Poser, Poser, S. Positron emission tomography with [18F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD). J Neurol 2002; 249: 699-705

Arlt, S., Kontush, A., Zerr, I., Buhmann, C., Jacobi, C., Schröter, A., Poser, S., Beisiegel, U. Increased lipid peroxidation in cerebrospinal fluid and plasma from patients with Creutzfeldt-Jakob disease. Neurobiol Dis 2002; 10: 150-156
Mollenhauer, B., Zerr, I., Ruge, D., Krause, G., Mehnert, W. H., Kretzschmar, H. A., Poser, S. Epidemiology and clinical symptomatology of Creutzfeldt-Jakob disease. DMW 2002; 127(7): 312-317

2001
Schröder, B., Franz, B., Hempfling, P., Selbert, M., Jürgens, T., Kretzschmar, H. A., Bodemer, M., Poser, S., Zerr, I. Polymorphisms within the prion-like protein gene (Prnd) and their implications in human prion diseases, Alzheimer's disease and other neurological disorders. Hum Genet 2001; 109:319-325

Völkel, D., Zimmermann, K., Zerr, I., Lindner, T., Bodemer, M., Poser, S., Schwarz, H.P. C-reactive protein and IL-6: new marker proteins for the diagnosis of CJD in plasma? Transfusion 2001; 41:1509-1514

The EUROCJD Group, Writing Committee: Alpérovitch, A., Zerr, I., Windl, O., Poser, S., Pocchiari, P., van Duijn, C. M., Mitrova, E., Will, R. G. Genetic epidemiology of Creutzfeldt-Jakob disease in Europe. Rev Neurol (Paris) 2001; 157:633-637

Tschampa, H.J., Neumann, M., Zerr, I., Henkel, K., Schröter, A., Schulz-Schaeffer, W.J., Steinhoff, B.J., Kretzschmar, H.A., Poser, S. Patients with Alzheimer disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001; 71: 33-39

Zerr, I. Clinical diagnostic tests in human prion diseases. Arch Ins Neurol 2001; 1:45-48

Völkel, D., Zimmermann, K., Zerr, I., Bodemer, M., Poser, S., Lindner, T., Turecek, P.L., Schwarz, H.P. Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases. Transfusion 2001; 41:441-447

2000
Zerr, I., Schulz-Schaeffer, W.J., Giese, A., Bodemer, M., Schröter, A., Henkel, K., Tschampa, H., Windl, O., Pfahlberg, A., Steinhoff, B., Gefeller, O., Kretzschmar, H.A., Poser, S. Current clinical diagnosis of CJD: identification of uncommon variants. Ann Neurol 2000; 48: 323-329

Zerr, I., Pocchiari, M., Collins, S., Brandel, J.P., de Pedro Cuesta, J., Knight, R., Bernheimer, H., Cardone, F., Delasnerie-Lauprêtre, N., Cuadrado-Corrales, N., Ladogana, A., Bodemer, M., Fletcher, A., Awan, T., Ruiz Bremon, A., Budka, H., Laplanche, J.L., Will, R.G., Poser, S. Analysis of EEG and CSF 14-3-3 proteins as  aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55:811-815

Zerr, I., Brandel, J.-P., Masullo, C., Wientjens, D.P.W.M., de Silva, R., Zeidler, M., Granieri, E., Sampaolo, S., van Duijn, C., Delasnerie-Lauprêtre, N., Will, R.G., Poser, S. European surveillance on Creutzfeldt-Jakob disease: A case-control study for medical risk factors. Journal of Clinical Epidemiology 2000; 53: 747-754

Schröter, A., Zerr, I., Henkel, K., Tschampa, H., Finkenstaedt, M., Poser, S. Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch Neurol 2000; 57: 1751-1757

Brown, P., Preece, M., Brandel, J.-P., Sato, T., McShane, L., Zerr, I., Fletcher, A., Will, R.G., Pocchiari, M., Cashman, N.R., d’Aignaux, J.H., Cervenákova, L., Fradkin, J., Schonberger, L.B., Collins, S.J. Iatrogenic Creutzfeldt-Jakob disease at the millenium. Neurology 2000; 55: 1075-1081

Bieschke, J., Giese, A., Schulz-Schaeffer, W., Zerr, I., Poser, S., Eigen, M., Kretzschmar, H. A.: Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. PNAS 2000; 97:5468-5473
Otto, M., Esselmann, H., Schulz-Schaeffer, W., Neumann, M., Schröter, A., Ratzka, P., Cepek, L., Zerr, I., Steinacker, P., Windl, O., Kornhuber, J., Kretzschmar, H.A., Poser, S., Wiltfang, J. Decreased levels of ß-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurology 2000; 54: 1099-1102

Bleich, S., Kropp, S., Degner, D., Zerr, I., Pilz, J., Gleiter, C.H., Otto, M., Rüther, E., Kretzschmar, H.A., Wiltfang, J., Kornhuber, J., Poser, S. Creutzfeldt-Jakob disease and oxidative stress. Acta Neurol Scand 2000; 101: 332-334

Zeidler, M., Green, A.J., Zerr, I. Case 28-1999: Creutzfeldt-Jakob disease. N Engl J Med 2000; 342: 292-293

Kropp, S., Finkenstaedt, M., Zerr, I., Schröter, A., Poser, S. Diffusion-weighted MRI in patients with Creutzfeldt-Jakob disease. Nervenarzt 2000; 71: 91-95

Kropp, S., Riedemann, C., Zerr, I., Schröter, A., Poser, S. Perspectives on medical research by relatives of patients with Creutzfeldt-Jakob disease. Psychiat Prax 2000; 27: 248-51

1999
Alpérovitch, A., Zerr, I., Pocchiari, M., Mitrova, E., de Pedro Cuesta, J., Hegyi, I., Collins, S., Kretzschmar, H.A., van Duijn, C., Will, R.G. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 1999; 353: 1673-1674

Wiltfang, J., Otto, M. Baxter H.C., Bodemer, M., Steinacker, P., Bahn, E., Zerr, I., Kornhuber, J., Kretzschmar, H.A., Poser, S., Aitken, A. Isoform pattern  of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurochem 1999; 73: 2485-2490

Windl, O., Giese, A., Schulz-Schaeffer, W.J., Zerr, I., Skworc, K., Arendt, S., Oberdieck, C., Bodemer, M., Poser, S., Kretzschmar, H.A. Molecular genetics of human prion diseases in Germany. Hum Genet 1999; 105: 244-252

Parchi, P., Giese, A., Capellari, S., Brown, P., Schulz-Schaeffer, W.J., Windl, O., Zerr, I., Budka, H., Kopp, N., Piccardo, P., Poser, S., Rojiani, A., Streichem-berger, N., Julien, J., Vital, C., Ghetti, B., Gambetti, P., Kretzschmar, H.A. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224-233

Poser, S., Mollenhauer, B., Kraus, A., Zerr, I., Steinhoff, B., Schröter, A., Finkenstaedt, M., Schulz-Schaeffer, W., Kretzschmar, H.A., Felgenhauer K. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 1999; 122: 2345-2351

Laske, C., Gefeller, O., Pfahlberg, A., Zerr, I., Schröter, A., Kretzschmar, H.A., Poser, S. The effect of stress on the onset and progression of  Creutzfeldt-Jakob disease: results of a German pilot case-control study. European Journal of Epidemiology 1999; 15:631-635

Kropp, S., Zerr, I., Schulz-Schaeffer, W., Riedemann, Chr., Bodemer, M., Laske, C., Kretzschmar, H.A., Poser, S. Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease. Neuroscience Letters 1999; 261: 124-126

Skworc, K., Windl, O., Schulz-Schaeffer, W.J., Giese, A., Bergk, J., Nägele, A., Vieregge, P., Zerr, I., Poser, S., Kretzschmar, H.A. Familial Creutzfeldt-Jakob disease with a novel 120-bp insertion in the prion protein gene. Ann Neurol 1999; 46(5): 693-700

Seipelt, M., Zerr, I., Nau, R., Mollenhauer, B., Kropp, S., Steinhoff, B.,  Wilhelm-Gössling, C., Bamberg, Chr., Janzen, R.W.C., Berlit, P., Manz, F., Felgenhauer, K., Poser, S. Hashimoto encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease. JNNP 1999; 66:172-176

Kropp, S., Schulz-Schaeffer, W.,  Finkenstaedt, M, Riedemann, Chr., Windl. O., Steinhoff, B., Zerr, I., Kretzschmar, H.A., Poser, S. The „Heidenhain“ variant of  Creutzfeldt-Jakob disease. Arch Neurology 1999; 56:55-61

Marienhagen, J., Weingärtner, U., Zerr, I., Poser, S., Blaha, L., Eilles, C. Hirn-SPECT mit Tc-99m Bicisat (ECD) bei rasch progredientem dementiellemnSyndrom. Nuklearmedizin 1999; 38(6): 203-206

Riedemann, Chr., Zerr, I., Kropp, S., Otto, A., Poser, S., Herrmann, C. Verlauf von Angst, Depressivität und Lebensqualität bei Angehörigen von Creutzfeldt-Jakob Kranken. Zsch  Psychosom  Med. 1999; 45:128-141

1998
Otto, M., Zerr, I., Poser, S., Wiltfang, J., Schütz, E., Pfahlberg, A., Gefeller. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum. (letter) BMJ 1998; 317: 472-473.

Kretzschmar, H.A., Giese, A., Zerr, I., Windl, O., Schulz-Schaeffer, W.J., Skworz, K., Poser, S. The German FFI cases. Brain Pathology 1998; 8: 559-561

Zerr, I., Giese, A., Windl, O., Kropp, S., Schulz-Schaeffer, W.J., Riedemann, C., Skworc, K., Bodemer, M., Kretzschmar, H.A., Poser, S. Phenotypic variability in Fatal Familial Insomnia (D178-129M) genotype. Neurology 1998; 51: 1398-1404

Zerr, I., Bodemer, M., Gefeller, O., Otto, M., Poser, S., Wiltfang, J., Windl, O., Kretzschmar, H.A., Weber, T. Detection of 14-3-3 protein in cerebrospinal fluid strongly supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43 (1): 32-40

Will R.G., Alpérovitch, A., Poser, S., Pocchiari, M., Hofman, A., Mitrova, E., de Silva, R., D`Alessandro, M., Brandel, J.-P., Zerr, I., van Duijn, C. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. Ann Neurol 1998; 43(6):763-767

van Duijn C., Delasnerie-Laupretre, N., Masullo, C., Zerr, I., de Silva, R., Wientjens, D.P.W.M., Brandel, J.-P., Weber, T., Almonti, S., Zeidler, M., Alpérovitch, A., Poser, S., Granieri, E., Hofman, A., Will, R.G. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-1995. Lancet 1998; 351:1081-1085.

Otto, A., Zerr, I., Lantsch, M., Weidehaas, K., Riedemann, Chr., Poser, S. Akinetic mutism as a classification criterion for the diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosur Psychiatry 1998; 64(4): 524-528

Otto, M., Wiltfang, J., Schütz, E., Zerr, I., Otto, A., Pfahlberg, A., Gefeller, O., Uhr, M., Giese, A., Weber, T., Kretzschmar, H.A., Poser, S. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum. BMJ 1998; 316 (7131): 577-582

Kropp, S., Riedemann, C., Zerr, I., Poser, S. Wollen Angehörige von Creutzfeldt-Jakob Patienten genetisch aufgeklärt werden? DMW 1998; 123 (34/35): 1023-1024
Steinhoff, B., Herrendorf, G., Zerr, I., Poser, S. Creutzfeldt-Jakob disease. A sphinx of modern neurobiology. DMW 1998; 123 (6):169

1997
Otto, M., Stein, H., Szudra, A., Zerr, I., Bodemer, M., Gefeller, O., Schulz-Schäfer, W.J., Kretzschmar, H.A., Mäder, W., Poser, S., Weber, T. S100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol 1997; 244: 566-570

Zerr, I., Bodemer, M., Weber, T. The 14-3-3 brain protein and transmissible spongiform encephalopathy. N Engl J Med 1997; 336: 874

Otto, M., Wiltfang, J., Tumani, H., Zerr, I., Lantsch, M., Kornhuber, J., Weber, T., Kretzschmar, H.A., Poser, S. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neuroscience Letters 1997; 225: 210-212

Poser, S., Zerr, I., Schulz-Schaeffer, W.J., Kretzschmar, H.A., Felgenhauer, K. The Creutzfeldt-Jakob disease. A sphinx of current neurobiology. DMW 1997; 122: 1099-1105

1996
Zerr, I., Helmhold, M., Poser, S., Armstrong, V. W., Weber, T. Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt-Jakob disease. Arch Neurol 1996; 53: 1233-1238

Zerr, I., Bodemer, M., Otto, M., Poser, S., Windl, O., Kretzschmar, H.A., Gefeller, O., Weber, T. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet 1996; 348: 846-849

Steinhoff, B. J., Racker, S., Herrendorf, G., Poser, S., Grosche, S., Zerr, I., Kretzschmar, H.A., Weber, T. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 1996; 53: 162-166

Finkenstaedt, M., Szudra, A., Zerr, I., Poser, S., Hise, J. H., Stoebner, J. M., Weber, T. MR imaging of Creutzfeldt-Jakob disease. Radiology 1996; 199:793-798

Poser, S., Weber, T., Zerr, I., Giese, A., Gefeller, O., Felgenhauer, K., Kretzschmar, H. Keine Häufung der Creutzfeldt-Jakob-Krankheit in der Bundesrepublik Deutschland. Dt Ärztebl 1996; 93: A-2149-2150

1995
Zerr, I., Bodemer, M., Räcker, S., Grosche, S., Poser, S., Kretzschmar, H. A., Weber, T. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995; 345: 1609-1610

Zerr, I., Helmhold, M., Weber, T., Armstrong, VW. Apolipoprotein E in Creutzfeldt-Jakob disease. Lancet 1995; 345: 68-69

Bogumil T., Jacobsen, Th., Windl, O., Giese, A., Beuche, W., Zerr, I., Räcker, S., Grosche, S., Szudra, A., Poser, S., Weber, T., Kretzschmar, H.A. Cerebellar changes in sporadic Creutzfeldt-Jakob disease: a synopsis of clinical, histological, immunohistochemical and genetic data. E J Pathol 1995; 1:3

Krasemann, S., Zerr, I., Weber, T., Poser, S., Kretzschmar, H. A., Hunsmann, G., Bodemer, W. Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene. Molecular Brain Research 1995; 34: 173-176

Noch, S., Zerr, I., Poser, S., Hunsmann, G., Bodemer, W. A novel insertion mutant comprising nine extra octapeptide repeats within the human prion gene. Med Genetik 1995; 2: 266-267

 

Übersichtsarbeiten

Zerr, I. Therapeutic trials in human transmissible songiform encephalopathies: recent advances and problems to address. Infectious Disorders - Drug Targets  2009, 9 (1):92-9.

Zerr, I. Creutzfeldt-Jakob Erkrankung: Phänomenologie und therapeutsche Ansätze. Ärztliche Praxis Neurologie/Psychiatrie, 2008, 5: 44-49.

Heinemann, U., Weiss, S., Zerr, I. Therapeutic approaches for  treatment of Creutzfeldt-Jakob disease. Med Monatsschr Pharm, 2008, 10:378-384

Ludewigs, H., Zuber, Ch., Vana, K., Nikles, D., Zerr, I., Weiss, S.Therapeutic approaches for prion disorders.Expert Review of Anti-infective Therapy. 2007, 5(4): 613-630

Heinemann, U., Zerr, I. Demenzen: Pathogenese, neurochemische Diagnostik sowie reversible Demenzsyndrome. Neuroforum, 2007, 2: 47-54

Heinemann, U., Weih, M., Wiltfang J., Zerr I. Früh beginnende und rasch verlaufende Demenzen. Psychiatrie und Psychotherapie up2date. 2007, 1: 321-336

Heinemann, U., Gloeckner, F., Varges, D., Meissner, B., Krasnianski, A., Zerr. I. Differentialdiagnose rasch progredienter Demenzen. Zeitschrift für Gerontopsychologie und-psychiatrie. 2007, 20 (1), 17-26

Von Auer, F., Burger, R., Buschmann, A., Dietz, K., Heiden, M., Hitzler, WE, Klamm, H., Kreil, T., Kretszchmar, HA, Nübling, M., Offergeld, R., Pauli, G., Schottstedt, V., Seitz, R., Volkers, P., Zerr, I. Overall blood supply strategy with regard to Variant Creutzfeldt-Jakob disease (VCJD). Report of the Working group Commissioned by the German Federal Ministry of Health. Transfusion Medicine and Hemotherapy. 2006, Vol. 33, Suppl. 2

Krasnianski, A., Meissner, B., Heinemann, U., Zerr, I. Clinical  findings  and diagnostic  tests in CJD and vCJD. Folia Neuropathol  2006; 42:24-38.

Blümel, J., Burger, R., Gerlich, W., Gürtler, L., Heiden, M., Hitzler, W., Jansen, B., Klamm, H., Ludwig, W-D., Montag-Lessig, T., Offergeld, R., Paessens, A., Pauli, G., Seitz, R., Schlenkrich, U., Schottstedt, V., Willkommen, H., Beekes, M., Zerr, I. (AK Blut des BMGS). Variante Creutzfeldt-Jakob-Krankheit. Budesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2005;48 (9): 1082-90.

Blumel, J., Burger, R., Gerlich, W., Gurtler, L., Heiden, M., Hitzler, W., Jansen, B., Klamm, H., Ludwig, W. D., Montag-Lessing, T., Offergeld, R., Paessens, A., Pauli, G., Seitz, R., Schlenkrich, U. Schottstedt, V., Willkommen, H., Beekes, M., Zerr, I. Variant Creutzfeldt-Jakob disease. Transfusion Medicine and Hemotherapy 2005; 32: 227-236.

Poser, S., Bartl. M., Jastrow, U., Körtner, K., Molelnhauer, B.,  Schneider-Dominco, M. , Zerr, I. Prion induced diseases. Transplantationsmedizin 2003, 15 (1):60-63

Zerr, I. Die Creutzfeldt-Jakob-Krankheit, deren Variante und klinische Diagnose. Die Medizinische Welt; 2003, 54/11: 293-299.

Zerr I, Poser S. Creutzfeldt-Jakob Krankheit: Zusammenspiel von Genetik und Umweltfaktoren. Neuroforum 2003,

Zerr I., Poser S. Diagnostik und Klinik der CJK. Der Kassenarzt 2003; 16: 26-29

Zerr, I., Poser, S. Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests. APMIS 2002; 110(1): 88-98.

Poser, S., Zerr, I. Klinik, Diagnostik und Therapiemöglichkeiten der menschlichen Prionerkrankungen. Internist 2002; 43: 731-737

Poser, S., Zerr, I., Felgenhauer, K. Die neue Variante der Creutzfeldt-Jakob-Krankheit. DMW 2002; 127(7): 331-334

Zerr, I., Mollenhauer, B., Werner, C., Poser, S. Früh- und Differentialdiagnose der Creutzfeldt-Jakob-Krankheit. DMW 2002; 127(7): 323-327

v. Rheinbaben, F., Appel, T.,  Zerr, I. Spongiforme Enzephalopathien: Zum Umgang mit Creutzfeldt-Jakob Patienten. Endo-Praxis 2000; 16 (2): 6-12

Poser, S., Zerr, I., Schröter, A., Otto, M., Giese, A., Steinhoff, B.J., Kretzschmar H.A. Clinical and differential diagnosis of Creutzfeldt-Jakob disease. Arch Virol 2000; (Suppl) 16: 153-159

Otto, M., Zerr, I., Wiltfang, J., Weber, T., Kretzschmar, H.A., Poser, S., Felgenhauer, K. Laborchemische Verfahren in der Differentialdiagnose der Creutzfeldt-Jakob-Krankheit. Dt Ärtztebl 1999; 96: A-3097-3102 (Heft 48)

Riedemann, Chr., Giese, A., Kropp, S., Zerr, I., Schulz-Schaeffer, W., Poser, S.,  Kretzschmar, H.A. Die Creutzfeldt-Jakob Krankheit. MTA 1998; 13 (11): 796-804

Weber, T., Otto, M., Bodemer, M., Zerr, I. Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies. Biomed Pharmacotherapy 1997; 51 (9): 381-387

Zerr, I., Otto, A., Riedemann, C., Poser, S. Neue Variante der Creutzfeldt-Jakob Krankheit. Ätiologie und klinische Besonderheiten. Zeitschrift für Allgemeinmedizin 1997; 73:507-511

Poser S., Zerr, I., Weidehaas, K. Epidemiological and clinical features of Creutzfeldt-Jakob disease (CJD). Biotest Bulletin 1997; 5: 359-361

Weber, T., Zerr, I., Bodemer, M., Poser, S. Expanded illness spectrum of human spongiform encephalopathies or prion diseases. Nervenarzt 1997; 68(4): 309-323.

 

Buchbeiträge

Zerr, I., Bähr, M. Human transmissible spongiform encephalopathies. in: Lang F. (Hrsg.): Encyclopedic Reference of Molecular Mechanisms of Disease. Springer-Verlag, 2009 in press

Zerr, I. Clinical and therapeutic aspects of prion disease, in: C. Duyckaerts, I. Litvan (Hrsg.): Dementias 1, Handbook of Clinical Neurology series, 3rd Edition. Elsevier Limited, Edinburgh 2008 Vol 89: 737-764.

Zerr, I., Budka, H., Sturzenegger, M., Steinhoff, B. J., Urbach, H., Kallenberg, K,  Schulz, J. B.,  Creutzfeldt-Jakob-Krankheit, in: H. C. Diener, für die Kommission „Leitlinien" der Deutschen Gesellschaft für Neurologie (Hrsg.): Leitlinien für Diagnostik und Therapie in der Neurologie. 4., überarbeitete Auflage. Thieme, Stuttgart, 2008: 469-474

Zerr, I. Methods for the Clinial Diagnosis of Human Prion Diseases. in: B. Hörnlimann, D. Riesner, H. A. Kretzschmar (Hrsg.): Prions and Prion Diseases. Walter de Gruyter, Berlin, New York 2006: 363-381

Zerr, I., Poser, S. Epidemiology and Risk Factors of Creutzfeldt-Jakob Disease. in: B. Hörnlimann, D. Riesner, H. A. Kretzschmar (Hrsg.): Prions and Prion Diseases. Walter de Gruyter, Berlin, New York 2006 :423-432

Zerr, I., Poser, S., Kretzschmar, H. A.: Creutzfeldt-Jakob disease in Germany, in: B. Hörnlimann, D. Riesner, H. A. Kretzschmar (Hrsg.): Prions and Prion Diseases. Walter de Gruyter, Berlin, New York 2006: 433-439

Boesenberg-Grosse, C., Schulz-Schaeffer, W.J., Zerr, I. Brain-derived proteins in the cerebrospinal fluid and neuropathological lesion profiles in CJD. In: Alzheimer’s Disease: New Advances. Ed. Iqbal, K., Winblad, B., Avila, J. Medimont International Proceedings. 2006; 115-120.

Poser, S., Zerr, I. Möglichkeiten und Bedeutung neurobiochemischer Diagnostik, in: Wallesch (Hrsg.): Neurologie – Diagnostik und Therapie in Klinik und Praxis. 1. Auflage. Urban & Fischer, München, 2005.

Zerr, I., Janzen, R. W. C., Schulz, J. B., Steinhoff, B. J., Urbach, H.: Creutzfeldt-Jakob-Krankheit, in: H. C. Diener, für die Kommission „Leitlinien" der Deutschen Gesellschaft für Neurologie (Hrsg.): Leitlinien für Diagnostik und Therapie in der Neurologie. 3., überarbeitete Auflage. Thieme, Stuttgart, 2005: 317-322.

Zerr, I. Klinische Diagnose und Epidemiologie der Creutzfeldt-Jakob-Krankheit. In: Fortschritt und Fortbildung in der Medizin. Bundesärztekammer, Band 27 (2003/2004). S. 40-46

Zerr, I., Poser, S. Epidemiology and risk factors of transmissible spongiform encephalopathies (TSE) in man. in: H. F. Rabenau, J. Cinatl, Doerr, H. W. (Hrsg.): Prions. A challenge for science, medicine and public health system. Contributions to microbiology. S. Karger AG, Basel, 2004;11:98-116.

Zerr, I.,Schulz-Schaeffer, W. Neue Variante der Creutzfeldt-Jakob-Krankheit, in: Henkes, Kölmel (Hrsg.):“Die entzündlichen Erkrankungen des Zentralnervensystems“. Ecomed Verlagsgesellschaft AG, Landsberg, 2003

Zerr, I.: Der Beitrag von Liquoruntersuchungen zur Frühdiagnose der Creutzfeldt-Jakob-Erkrankung, Shaker Verlag, Aachen, 2003

Zerr, I., Janzen, R. W. C., Schulz, J. B., Steinhoff, B. J., Urbach, H.: Creutzfeldt-Jakob-Krankheit, in: H. C. Diener, für die Kommission „Leitlinien" der Deutschen Gesellschaft für Neurologie (Hrsg.): Leitlinien für Diagnostik und Therapie in der Neurologie. 2., überarbeitete Auflage. Thieme, Stuttgart, 2003: 216-219

Zerr, I. Differentialdiagnostik präseniler Demenzen. Sonderband Aktuelle Neurologie, Fortbildungsband der 75. Jahrestagung der Deutschen Gesellschaft für Neurologie. Thieme 2002, Herausgeber: W. Hacke, M. Hennerici, H.C. Diener, K. Felgenhauer, C.W. Wallesch, E. Busch, S. 460-462

Zerr, I. Epidemiologie der Prionenerkrankungen". Sonderband Aktuelle Neurologie, Fortbildungsband der 75. Jahrestagung der Deutschen Gesellschaft für Neurologie. Thieme 2002, Herausgeber: W. Hacke, M. Hennerici, H.C. Diener, K. Felgenhauer, C.W. Wallesch, E. Busch, S.

Zerr, I., Janzen, R. W. C., Schulz, J. B., Steinhoff, B. J., Urbach, H.: Creutzfeldt-Jakob-Krankheit, in: H. C. Diener und W. Hacke, für die Kommission „Leitlinien" der Deutschen Gesellschaft für Neurologie (Hrsg.): Leitlinien für Diagnostik und Therapie in der Neurologie. 1. Auflage. Thieme, Stuttgart, 2002: 38-41

Zerr, I. Phänotypische Charakteristika der sporadischen Creutzfeldt-Jakob Krankheit. Sonderband Aktuelle Neurologie, Fortbildungsband der 74. Jahrestagung der Deutschen Gesellschaft für Neurologie. Thieme 2001, Herausgeber: J. Noth, H.C. Diener, K. Felgenhauer, C.W. Wallesch, E. Busch, S. 521-523

Zerr, I. und Poser, S.: Epidemiology and risk factors of transmissible spongiform encephalopathies in man, in: H. F. Rabenau, J. Cinatl, Doerr, H. W. (Hrsg.): Prions. A challenge for science, medicine and public health system. Contributions to microbiology. S. Karger AG, Basel, 2001, 7: 93-104

Zerr, I. und Poser, S.: Die klinischen Diagnostikmethoden bei Prionkrankheiten des Menschen, in: B. Hörnlimann, D. Riesner, H. A. Kretzschmar (Hrsg.): Prionen und Prionkrankheiten. Walter de Gruyter, Berlin, New York 2001: 261-271

Zerr, I. und Poser, S.: Die Epidemiologie und Risikofaktoren der Creutzfeldt-Jakob-Krankheit, in: B. Hörnlimann, D. Riesner, H. A. Kretzschmar (Hrsg.): Prionen und Prionkrankheiten. Walter de Gruyter, Berlin, New York 2001: 299-305

Zerr, I., Gefeller, O., Kretzschmar, H. A. und Poser, S.: Die epidemiologische Erfassung der Prionkrankheiten des Menschen, in: B. Hörnlimann, D. Riesner, H. A. Kretzschmar (Hrsg.): Prionen und Prionkrankheiten. Walter de Gruyter, Berlin, New York 2001: 306-311

Zerr, I. Übertragbare Spongiforme Enzephalopathien (Prionerkrankungen). B7-1 - 8. Aktuelle Neurologie, Fortbildungsband der 72. Jahrestagung der Deutschen Gesellschaft für Neurologie. Thieme 1999, Herausgeber: C.W. Wallesch, H.C. Diener, K. Felgenhauer, F. Wiegand

Zerr, I., Gefeller, O., Otto, A., Riedemann, Chr., Bodemer, M., Poser, S. Epidemiologische Untersuchungen der Creutzfeldt-Jakob Erkrankung in der Bundesrepublik Deutschland In: R. Muche, G. Büchele, D. Harder, W. Gaus (Eds.): Medizinische Informatik, Biometrie und Epidemiologie. 42. Jahrestagung der Deutschen Gesellschaft für Informatik, Biometrie und Epidemiologie (GMDS), Ulm, September 1997, MMV Medizin Verlag, München:450-454